DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
VEGF signaling pathway	R-HSA-194138	map04370	proguanil	3242	drug-path
Bladder cancer	R-HSA-9700206	map05219	proguanil	3242	drug-path
Long-term potentiation	R-HSA-9620244	map04720	proguanil	3242	drug-path
ErbB signaling pathway	R-HSA-168638	map04012	proguanil	3242	drug-path
Non-small cell lung cancer	R-HSA-5619066	map05223	proguanil	3242	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	proguanil	3242	drug-path
Endometrial cancer	R-HSA-2077421	map05213	proguanil	3242	drug-path
GnRH signaling pathway	R-HSA-168638	map04912	proguanil	3242	drug-path
Colorectal cancer	R-HSA-4791275	map05210	proguanil	3242	drug-path
Vascular smooth muscle contraction	R-HSA-445355	map04270	proguanil	3242	drug-path
T cell receptor signaling pathway	R-HSA-983705	map04660	risperidone	5073	drug-path
Olfactory transduction	R-HSA-9751605	map04740	risperidone	5073	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	risperidone	5073	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	risperidone	5073	drug-path
Natural killer cell mediated cytotoxicity	R-HSA-5218921	map04650	tribenoside	196122	drug-path
Olfactory transduction	R-HSA-9751605	map04740	tribenoside	196122	drug-path
Axon guidance	R-HSA-422475	map04360	tribenoside	196122	drug-path
Bladder cancer	R-HSA-9700206	map05219	tribenoside	196122	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	tribenoside	196122	drug-path
Pathways in cancer	R-HSA-9824443	map05200	tribenoside	196122	drug-path